ICON Public Limited Company Accounts Payables 2011-2026 | ICLR

Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.

Main types of accounts payable

Type of liability	Example
To suppliers and contractors	Goods received but not yet paid for
Taxes and fees	VAT, income tax, etc., not paid on time
Salaries	Employee wages not paid
To budgets	Insurance contributions to funds not paid
To founders	Founders provided borrowed funds
To banks	Overdue loan payments
Other	Fines, penalties, forfeits, customer prepayments, etc.

Impact on the company's financial performance

Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios
Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence
Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals)
Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated

Annual Accounts Payables ICON Public Limited Company

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
173 M	132 M	81.2 M	90.8 M	51.1 M	24 M	13.3 M	18.6 M	8.7 M	7.02 M	2.79 M	4.59 M	8.15 M	5.34 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
173 M	2.79 M	44.3 M

Quarterly Accounts Payables ICON Public Limited Company

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	63.5 M	90.8 M	62.6 M	37.8 M	48.1 M	51.1 M	28.7 M	32.7 M	23.3 M	24 M	20.8 M	20.2 M	19.3 M	13.3 M	15.3 M	15.1 M	11.8 M	18.6 M	13 M	7.86 M	13.6 M	8.7 M	5.05 M	6.12 M	5.65 M	7.02 M	4.53 M	6.3 M	3.86 M	2.79 M	5.91 M	10.9 M	6.66 M	4.59 M	8.85 M	11.8 M	6.79 M	8.15 M	9.33 M	8.07 M	5.49 M	5.34 M	6.52 M	4.29 M	8.61 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
90.8 M	2.79 M	17.6 M

Accounts Payables of other stocks in the Diagnostics research industry

Issuer	Accounts Payables	Price	% 24h	Market Cap	Country
Bioventus BVS	10.9 M	$ 9.19	2.06 %	$ 612 M	USA
Biodesix BDSX	2.19 M	$ 15.31	4.22 %	$ 1.99 B	USA
Akumin AKU	36.6 M	-	-17.87 %	$ 25.9 M	Canada
Enzo Biochem ENZ	1.38 M	-	-8.98 %	$ 14.8 K	USA
Check-Cap Ltd. CHEK	952 K	-	-	$ 9.42 M	Israel
Lantheus Holdings LNTH	42.9 M	$ 74.11	-2.15 %	$ 5 B	USA
DermTech DMTK	1.48 M	-	-11.32 %	$ 2.94 M	USA
Aspira Women's Health AWH	881 K	-	-6.19 %	$ 10.5 M	USA
Co-Diagnostics CODX	1.48 M	$ 4.4	101.83 %	$ 129 M	USA
Accelerate Diagnostics AXDX	4.5 M	-	-61.36 %	$ 2.46 M	USA
Medpace Holdings MEDP	28.1 M	$ 463.46	1.43 %	$ 13.4 B	USA
Global Cord Blood Corporation CO	8.33 M	-	-	$ 399 M	China
Charles River Laboratories International CRL	149 M	$ 159.84	1.16 %	$ 7.92 B	USA
IQVIA Holdings IQV	322 M	$ 165.65	-0.81 %	$ 28.5 B	USA
Myriad Genetics MYGN	30 M	$ 4.67	0.11 %	$ 432 M	USA
Biocept BIOC	1.52 M	-	-13.05 %	$ 7.29 M	USA
National Research Corporation NRC	1.17 M	$ 17.26	-1.46 %	$ 386 M	USA
Invitae Corporation NVTA	14 M	-	-	$ 21.2 M	USA
BioNano Genomics BNGO	5.59 M	$ 1.22	-16.44 %	$ 6.64 M	USA
Mettler-Toledo International MTD	267 M	$ 1 261.71	1.72 %	$ 26 B	Schweiz
Interpace Biosciences IDXG	1.66 M	$ 1.71	0.73 %	$ 7.5 M	USA
Illumina ILMN	221 M	$ 125.17	1.11 %	$ 19.9 B	USA
Pacific Biosciences of California PACB	20.8 M	$ 1.38	-1.08 %	$ 414 M	USA
QIAGEN N.V. QGEN	83.3 M	-	-	$ 10.6 B	Niderland
Precipio PRPO	622 K	$ 27.01	0.3 %	$ 35.1 M	USA
Celcuity CELC	9.37 M	$ 101.12	-5.27 %	$ 3.99 B	USA
Personalis PSNL	6.4 M	$ 7.67	0.72 %	$ 454 M	USA
Chembio Diagnostics CEMI	3.34 M	-	0.22 %	$ 16.8 M	USA
Laboratory Corporation of America Holdings LH	841 M	$ 266.56	0.81 %	$ 22.2 B	USA
RadNet RDNT	153 M	$ 59.22	-4.09 %	$ 4.45 B	USA
ENDRA Life Sciences NDRA	270 K	$ 3.49	0.29 %	$ 1.87 M	USA
NeoGenomics NEO	23.1 M	$ 7.87	-2.82 %	$ 1.01 B	USA
Natera NTRA	31.1 M	$ 193.75	-3.17 %	$ 19.1 B	USA
Senseonics Holdings SENS	4.06 M	$ 6.63	0.08 %	$ 277 M	USA
Sotera Health Company SHC	78 M	$ 13.82	-0.43 %	$ 3.92 B	USA
CareDx, Inc CDNA	9.99 M	$ 17.65	0.51 %	$ 941 M	USA
Soleno Therapeutics SLNO	12.4 M	$ 30.84	-2.77 %	$ 1.57 B	USA
OPKO Health OPK	47.1 M	$ 1.14	-1.3 %	$ 791 M	USA
Castle Biosciences CSTL	6.9 M	$ 25.23	-2.02 %	$ 701 M	USA
DarioHealth Corp. DRIO	2.93 M	$ 8.05	7.27 %	$ 32.1 M	Israel
DexCom DXCM	344 M	$ 66.28	0.51 %	$ 25.9 B	USA
Neuronetics STIM	10.7 M	$ 1.47	-8.12 %	$ 96.9 M	USA
Exact Sciences Corporation EXAS	176 M	$ 104.91	-	$ 19.8 B	USA